We have shown that intraperitoneal or inhaled therapeutic doses of PDE5 inhibitors corrected CFTR-dependent chloride transport in nasal (Lubamba et al., 2008, 2011) and rectal (Dhooghe et al., 2013) mucosae of F508del-CF homozygous mice. This evidence concerns the gene PDE5A and cystic fibrosis.